New Agreement Includes Medidata RCM and eTMF Archive for End-to-End
Inspection Readiness and Collaboration

December 05, 2017 09:23 AM Eastern Standard Time

NEW YORK--(BUSINESS WIRE)--Medidata
(NASDAQ:MDSO), the leading global provider of cloud-based technology and
data analytics for clinical research, today announced that CytomX
Therapeutics, Inc., a biopharmaceutical company developing
investigational Probody™ therapeutics for the treatment of cancer, will
expand its partnership to include Medidata Regulated
Content Management (RCM) solutions, eTMF Archive and SOP Management.

With the addition of Medidata RCM, CytomX will now manage regulated and
nonregulated content in a single, unified platform. Accessible through
the Medidata
Clinical Cloud®, CytomX will integrate standard operating procedure
(SOP) management and electronic trial master file (eTMF) archive to
manage all content, data and workflows.

CytomX is also currently using Medidata
Rave®, the world’s leading solution for capturing, managing and
reporting patient data and Medidata
Balance®, randomization and trial supply management (RTSM)
application, for its oncology research studies.

“We’ve created a seamless offering with the Medidata platform that can
facilitate everything during clinical research, from data collection and
management to compliance,” said Mike Capone, chief operating officer at
Medidata. “Medidata’s industry difference is that we enable our
customers to take control of their data, helping them meet regulatory
requirements and ensure efficient clinical trials.”

About Medidata

Medidata
is reinventing global drug and medical device development by creating
the industry's leading cloud-based solutions for clinical research.
Through our advanced applications and intelligent data analytics,
Medidata helps advance the scientific goals of life sciences customers
worldwide, including over 950 global pharmaceutical companies, biotech,
diagnostic and device firms, leading academic medical centers, and
contract research organizations.

The Medidata Clinical Cloud® brings a new level of quality and
efficiency to clinical trials that empower our customers to make more
informed decisions earlier and faster. Our unparalleled clinical trial
data assets provide deep insights that pave the way for future growth.
The Medidata Clinical Cloud is the primary technology solution powering
clinical trials for 18 of the world's top 25 global pharmaceutical
companies and is used by 18 of the top 25 medical device developers—from
study design and planning through execution, management and reporting.